L. Houzet et al., Regulated control by granulocyte-macrophage colony-stimulating factor AU-rich element during mouse embryogenesis, BLOOD, 98(5), 2001, pp. 1281-1288
In vitro studies have indicated that the granulocyte-macrophage colony-stim
ulating factor (GM-CSF) gene expression is regulated at the posttranscripti
onal level by the AU-rich element (ARE) sequence present in its 3 ' untrans
lated region (UTR). This study investigated the importance of the ARE in th
e control of GM-CSF gene expression in vivo. For this purpose, transgenic m
ice bearing GM-CSF gene constructs containing or lacking the ARE (GM-CSF AU
(+) or GM-CSF AU(-), respectively) were generated. Both transgenes were und
er the transcriptional control of the immediate early promoter of the cytom
egalovirus (CMV) to ensure their early, widespread, and constitutive expres
sion. The regulation imposed by the ARE was revealed by comparing transgene
expression at day 14 of embryonic development (E14); only the ARE-deleted
but not the ARE-containing construct was expressed. Although GM-CSF AU(+) e
mbryos were phenotypically normal, overexpression of GM-CSF in E14 GM-CSF A
U(-) embryos led to severe hematopoietic alterations such as abnormal proli
feration of granulocytes and macrophages accompanied by an increased number
of peroxidase-expressing cells, their putative progenitor cells. These abn
ormalities compromise development because no viable GM-CSF AU(-) transgenic
pups could be obtained. Surprisingly, by E18, significant accumulation of
transgene messenger RNA was also observed in GM-CSF AU+ embryos leading to
similar phenotypic abnormalities. Altogether, these observations reveal tha
t GM-CSF ARE is a developmentally controlled regulatory element and highlig
ht the consequences of GM-CSF overexpression on myeloid cell proliferation
and differentiation. (C) 2001 by The American Society of Hematology.